Disclaimer: Consult with a doctor before deciding on a treatment plan for cancer or any other disease.
Emanuel Revici viewed cancer as a problem of pH. He cured cancer using elements, compounds, and lipids to increase his patients’ pH levels. Revici’s methods are innovative and complex. They must be administered by a qualified health professional who is knowledgeable about his treatment agents and strategies.
The Revici treatment is a pH-based treatment that uses elements and elemental compounds to treat cancer. Emanuel Revici saw cancer as a problem of high acidity in the body. According to his view, increasing the alkalinity of the body would cure the cancer. Dr. Revici used both elements, compounds, and lipids to increase the alkalinity of the body.
Revici’s treatment for cancer came under much scrutiny in the early to mid 20th century. Dr. Revici had his medical license revoked numerous times and was taken to court for his treatment methods. Originally from Romania, Dr. Revici emigrated to France briefly during World War II and later to Mexico City in 1941. In Mexico City he established a clinic where he treated cancer patients free of charge. In 1946 he moved to the United States and practiced/taught about his methods in both Chicago and New York, where he eventually established a clinic .
The treatment is sometimes called biologically-guided chemotherapy because of its use of certain chemical components in treating cancer, however it is not the same as conventional chemotherapy. Dr. Revici used concepts based on the periodic table and the body’s metabolic states and pH levels to cure cancer, thus invoking the term “chemotherapy” because his treatment method uses chemical compounds. One of the core elements that he used in the treatment of cancer was selenium. Other elements that Dr. Revici used included zinc, copper, calcium, and nickel. The chemical compounds he used had a dramatically lessened toxicity level, thus making it possible to use them in higher quantities to treat cancer .
Today, this treatment is controversial and difficult to find despite its success at treating cancer. Two treatment centers in the United States offer the treatment (see additional information below in the Other Important Information section) .
The Revici treatment has faced a lot of criticism because of its success at treating cancer. Dr. Revici started practicing medicine in France between 1935 and 1941, and eventually decided to move to Mexico City in 1941 to open his own clinic and research facility called the Instituto de Biologia Aplicada where he provided cancer treatments for free . A group of American physicians visited Revici’s clinic in Mexico to review his work and look into the new, successful form of cancer treatment. The physicians stated that Revici’s work was “extraordinary”. After this visit, attempts were made by multiple American organizations to document and study Revici’s work, but none were able to agree on research methods or procedures .
In 1946, Revici moved to the United States and started educating others about his method for cancer treatment (as well as the treatment of other diseases). In New York, Revici founded the Institute of Applied Biology to conduct research on cancer and other diseases; the institute was funded by the Cancer Research and Hospital Foundation until 1957 when they withdrew their support due to political pressure. However, the Cancer Control Research Foundation and the Gertrude Lawrence Foundation maintained their support .
In 1963, a clinical study was done on Revici’s methods. An initial agreement was laid out for how the study would be conducted, but unfortunately, the agreement was violated multiple times and participating scientists and doctors didn’t follow the treatment methods. Dr. Revici was not included in group discussions. Though Revici had great success at treating cancer himself, the clinical study was hijacked to make it look as though patients showed no improvement.
This situation is similar to what Dr. Gonzalez experienced when studies were done on his cancer treatment protocol. Researchers dramatically altered the protocol during the study and also failed to properly screen patients involved in the study (some patients were even put into the study without informed consent). There were numerous avoidable setbacks that made the scientific documentation of Dr. Gonzalez’s protocol delayed for longer than necessary. And, similar to Dr. Revici, Dr. Gonzalez’s effective cancer treatment was suppressed and viewed with much criticism by leaders in conventional medicine.
Dr. Revici’s story is also similar to Dr. Suguira’s at Sloan Kettering Memorial Hospital. Dr. Suguira was a well-respected doctor with an outstanding resume. He dedicated a substantial amount of time to studying vitamin B17/laetrile. While Dr. Suguira was able to demonstrate unequivocally that vitamin B17 effected a healing response, when the research was taken over by Sloan Kettering, the results were completely different because the research protocol was altered .
The American Medical Association (AMA) has the power to suspend and/or revoke the license of any doctor who mentions or recommends any type of alternative therapy or nutrition protocol to their cancer patients. This practice has been in place for 80+ years. Revici unfortunately had his license revoked by the AMA for this reason .
Safety and Effectiveness
Revici holds 17 US patents on chemical formulations for the treatment of various diseases, including cancer . With all of these 17 patents, the toxicity of the chemicals is one-thousandth less than that of their naturally occurring forms found in nature. For example, Revici was able to administer selenium to his patients at higher doses because he was able to bond selenium to a lipid to enable the body to process and absorb the mineral more efficiently and safely .
The Revici treatment is considered to be a safe cancer treatment with few side effects; some patients may experience nausea in certain cases, and inflammation or soreness may occur in the area of injections. In one study done with cancer patients who had been given less than 90 days to live, the patients’ survival was increased to an average 172 days with the use of the Revici treatment. The same study showed that 12 out of 53 of these patients who had breast cancer survived for a much longer period of time .
The results below were taken from Revici’s book on his treatment and abbreviated to give readers a sense of how this treatment works:
- A 59-year-old woman who had a mastectomy for adenocarcinoma 3 years prior had metastases to her ribs and liver. She had difficulty breathing, severe pain, and almost continuous vomiting. She was shown to have Offbalance A, and was treated with perselenide, bixine propanal, and epichlorohydrin. Her pain was significantly reduced shortly after the treatment started and eventually disappeared completely. The initially enlarged size of the woman’s liver went back to normal after three months of treatment, and the bone metastases in her ribs were shown to have completely disappeared. The woman recovered from the cancer and was able to continue on with her life with no issue.
- A 56-year-old man with a squamous cell carcinoma that caused severe pain and bleeding was treated using perselenide (by injection), epichlorohydrin, and bixine. Within 24 hours after the start of treatment, the man’s pain had disappeared, and after four days the bleeding had stopped. Ten days after the start of treatment the size of the tumor decreased and continued to decrease until it disappeared.
- A 60-year-old woman with a tumor in the gall bladder and metastases to the liver was experiencing difficulty breathing, pain, and a cough along with deep jaundice and a low body weight. She had complained of pain in the right side below the ribs (related to the possible existence of gallbladder stones) for 30 years. She was treated with epichlorohydrin, bixine, and perselenide. Her liver returned to a normal size, the fluid in her chest did not reproduce, and her stool color (initially clay colored) returned to normal.
- A 64-year-old man underwent an operation for a hypernephroma in the right kidney, and had 2 metastases to her femur, pelvic bones, and both lungs. He was treated with perselenide, bixine, and epichlorohydrin. After the start of treatment, he was soon able to sit up and walk a little. He was discharged from the hospital and then readmitted after having severe pain, and again was put on the treatment. The pain gradually went away and the femur showed recalcification; many metastases in the lungs disappeared, while some others showed a notable decrease in size.
- A 61-year-old woman had a partial cecostomy for adenocarcinoma. She was admitted to the hospital and put under the Revici treatment a month after the procedure for vaginal bleeding and erosion of the cervix caused by the same malignancy. The tumor filled the entire upper portion of the woman’s vagina, and had moved into the recto-vaginal wall. The woman was administered injections of perselenide, epichlorohydrin, and bixine. The bleeding and pain stopped after one week of treatment. At the time when Dr. Revici’s book was written, the patient was still under treatment and the lesion had shown regression.
- A 48-year-old man who had had a left nephrectomy for hypernephroma four years earlier had developed multiple lung metastases. He also had hemoptic sputum, an edema on the left leg, and severe pain in his back and leg. The man was treated with heptanol, butanol, and glycerol. After treatment started, the pain and the edema disappeared in 2-3 days and the lung metastases became softer and eventually started to reduce in size. In two months after treatment, the patient is able to go about his life normally with the metastases continuing to progressively decrease in size .
How the Revici Treatment Is Administered
Revici organizes cancer into 6 different hierarchical levels:
He also organizes cancer into 5 different stages:
- shock or end-stage
According to the Revici treatment, the metabolic processes of the body are said to regulate the development and regression of cancer; the anabolic (synthesis and growth) and catabolic (breakdown) forces must be in balance for healing to occur.
According to this treatment, cancer growth occurs because the body is overly anabolic, thus encouraging the out-of-control growth of cancer cells. The Revici treatment treats the cause of the cancer growth, a metabolic imbalance, rather than solely killing or removing the cancer by other means. In this way, the cancer is less likely to metastasize (because it isn’t given a direct route to another part of the body through surgery or other means) and is also more likely to stay gone since the body’s imbalances have been corrected.
The Revici method also aims to interrupt the cancer cells’ progress from stage-to-stage to avoid metastasis. Cancer cells have to go through numerous stages in order to become metastatic and any interruption in their progress inhibits their ability to continue .
Dr. Revici discovered that different lipids produce either a catabolic or anabolic effect on cells. For example, if fatty acids are a cell’s dominant lipid, the cell wall will be too permeable and the cell will leak; in this situation, potassium levels in the blood get higher because the potassium in the cells leaks out. Dr. Johanna Budwig also believed that fatty acids played an important role in cancer cell development and membrane activity. Additionally, Revici discovered that different elements produced anabolic or catabolic effects. The mineral selenium (and also zinc) has alone been noted as being a valuable cancer treatment, but Revici noted that this particular element had an especially “anti-anabolic” effect on cells. In the Revici treatment, selenium can be administered in quantities of up to one gram per day because of its ability to combine with lipids that allows for safe cell penetration. Other elements are also administered in a similar way where they are paired with a lipid to enable increased cell penetration .
How the Revici Treatment is Administered
Similar to the Gonzalez Protocol, the Revici treatment protocol varies from patient to patient and is based off of each individual’s unique health situation. Treatment begins by analyzing the pH of the patient’s blood and urine, as well as the patient’s body temperature .
Tests are done for 2-3 consecutive days to thoroughly analyze the patient’s state, after which time treatment may begin. The various diagnostic tests used in the Revici treatment include the following with their respective measures:
- Urine analyses: specific gravity, pH, surface tension, and the calcium excretion index are tested factors. In some cases, the chloride retention index may be tested as well.
- Blood analyses: potassium in serum and potassium in total blood are tested; chlorides in serum, leucocytes count, and eosinophiles count may be taken.
- Pain patterns
- Body temperature
According to different values obtained from these analyses, the patient’s imbalance may be deemed as an “Offbalance D” or “Offbalance A.” For example, the average pH level of urine is 6.2; if a patient has a higher pH than this, their disease may be “Offbalance A,” whereas if their urine has a lower pH their disease would be classified as being “Offbalance D.”
Using the Revici method other factors help classify the disease as well. If the tests taken show a clear pattern toward one Offbalance or another, treatment may be started with the use of special agents that work to bring the body back into balance; more similar tests may be done to ensure thorough coverage of the condition if the patient’s results are sporadic. Other specific measures may be taken in these cases also that are situation specific.
Targeting Different Levels of the Disease
Depending on the type of cancer, different agents may be used to target certain “levels” of disease. The levels are cellular, tissue, and organ/organism. For example, for a patient with an early stage cancer who still feels well and isn’t experiencing any symptoms, a cellular treatment method may be used. In contrast, a patient with a late stage cancer who is experiencing pain and other symptoms may receive a treatment that uses agents that work at an organ/organism level. Analyses such as pain pattern will help determine the level to be worked on in treatment. Some patients may show the need to have multiple “levels” worked on, but in treatment the most urgent level will be focused on.
Below are treatment agents used on different levels in the Revici method:
Anti-A Agents (Those meant to treat an “Offbalance D” disease):
∙ Propionic Aldehyde (used at an organ/organism level)
∙ Epichlorohydrin (used at a cellular level)
∙ Hexyl or heptyl diselenide (used at a cellular level)
∙ Tetralin persulfide or perselenide (used at tissue and cellular levels respectively)
∙ Sodium or magnesium thiosulfate (used at an organ/organism level)
∙ Lipoacids (used at a tissue level)
Anti-D Agents (Those meant to treat an “Offbalance A” disease):
∙ Heptanol (used at a cellular level)
∙ Polyunsaturated alcohols (used at a tissue level)
∙ Butanol (Used at an organ/organism level)
∙ Glycerol (used at an organ/organism level)
∙ Insaponifiable fraction of liver (used at a tissue level)
∙ Glycerophosphoric acid (used at an organ/organism level)
Treatment is started with small doses of the above agents. Tests continue being taken, and if offbalances persist the dosage is increased until there aren’t any offbalances. At this point, the dosage is continued for up to some months to ensure recovery. If the offbalance goes the other way (offbalance A to offbalance D, for example), the dosage is reduced until an adequate balance is again reached. After a few months of treatment, patients may be encouraged to take appropriate doses of particular agents to ward off a recurrence of the cancer .
During treatment, the patient’s diet and medication information is taken into account. Certain foods are anabolic, which in cancer patients means that these foods can encourage cancer growth. Foods such as sugar and salt are anabolic (growth-promoting), and patients are encouraged to avoid consuming these two foods during cancer treatment . Certain medications and supplements can have an effect on the body’s balance as well, thus affecting cancer growth. For example, quinine, caffeine, liver extracts, and vitamins A and D have an “Anti-A” effect on the body, while codeine, iron, insulin, and vitamins B1, B2, K, and E have an “Anti-D” effect on the body .
Other Important Information
Treatment centers that offer the Revici treatment include:
This clinic offers alternative cancer treatment heavily based on the Revici protocols.
Revici Life Science Center in New York City
This Center was established by Dr. Revici and is now believed to be operated by his grandson.
200 W 57th St.
New York, NY 10019
 N.A. (1989). Unproven Methods of Cancer Management: Revici Method. Retrieved May 8, 2018 from: https://onlinelibrary.wiley.com/doi/pdf/10.3322/canjclin.39.2.119
 Sircus, Mark (2015). Revici Selenium Cancer Treatment. Retreived May 8, 2018 from: http://drsircus.com/general/revici-selenium-cancer-treatment/
 Revici, Emanuel (1961). Research in pysiopathology as basis of guided chemotherapy; with special application to cancer. American Foundation for Cancer Research: New York, NY.
 Mankind Research Unlimited (2004). The Revici Method. Retrieved May 10, 2018 from: https://mankindresearchunlimited.weebly.com/dr-revici.html
 Kristal, Harold J. (2011). Dr. Revici’s Approach: A Metabolic Perspective. Retrieved May 10, 2018 from: http://www.bloodph.com/articles/DrRevici.asp
 McEvoy, Michael (2012). Emanual Revici, MD: Biological Hierarchy & His Approach to Cancer. Retrieved May 10, 2018 from: https://metabolichealing.com/emanuel-revici-md-biological-hierarchy-his-approach-to-cancer/
 Walters, Richard (1993). Options: The Alternative Cancer Therapy Book. Avery Publishing Group: New York, NY.
 Nigh, Greg, ND, LAc (2012). What Went Wrong: The Truth Behind the Clinical Trial of the Enzyme Treatment of Cancer – A review of Dr. Nicholas Gonzalez’s recent book. Retrieved May 25, 2018 from: https://www.naturalmedicinejournal.com/journal/2012-09/what-went-wrong-truth-behind-clinical-trial-enzyme-treatment-cancer
 Wells, S. D. (2012). 75% of the physicians in the world refuse chemotherapy for themselves. Retrieved June 1, 2018 from: https://www.naturalnews.com/036054_chemotherapy_physicians_toxicity.html
 Griffin, G. E. (1974). World Without Cancer: The Story of Vitamin B17, 3rd Ed. American Media.
 Budwig, J. (2010). The Budwig Cancer & Coronary Heart Disease Prevention Diet: The Complete Recipes, Updated Research & Protocols for Health and Healing. Freedom Press.